Monday, 9 February 2026
Focus Day Technology – AI in Pharma
From molecule to market: How much efficiency and quality lies in the AI revolution?
The Focus Day explores concrete application areas of artificial intelligence across the entire pharmaceutical value chain – from molecules to healthcare delivery. The emphasis: transferable business relevance and best practices.
09:45
Registration and Networking Breakfast
10:15
Welcome
10:20
Insights on current investigations and industry news from the Handelsblatt editorial team
Live Editorial
Helena Smolak
Editor for Pharmaceuticals – Handelsblatt
10:30
Scaling Agentic AI in Pharma – From Vision to Value
Keynote
Aditya Kudumala
Global Life Sciences & Healthcare AI Leader – Deloitte
Mehr Informationen
10:50
Artificial Intelligence in Healthcare Delivery: Opportunities and Limits Between Patients, Physicians and Industry
Panel Discussion
Moderator: Sandra Groeneveld, Editor & Host of “Handelsblatt Today” – Handelsblatt
Alexander Engel
Project Lead “Artificial Intelligence for Good Aging” – Federal Association of Senior Citizens’ Organisations (BAGSO)
Mehr Informationen
Andreas Pollner
General Manager – Moderna Germany
Mehr Informationen
Dr. Alexandra Widmer
Physician and Founder – docsdigtial
Mehr Informationen
AI for Discovery – Molecules & Targets: How Algorithms Accelerate the Development of New Therapeutics
11:10
AI Biotech in Action: How Multimodal Data Is Shaping the Next Generation of Drug Discovery and Development
Thomas Clozel
Chief Executive Officer – OWKIN – New York
11:30
Toward Pharmaceutical Superintelligence: From Speed Benchmarks to Genuine Invention
Ricardo Gaminha Pacheco
Longevity and Biotechnology Strategic Partnering, BD&L Director – Insilicio Medicine, Cambridge, USA
Mehr Informationen
11:50
From Superintelligence to Safe Innovation: How AI-Driven Drug Discovery Will Transform Evidence, Trials and Regulation
Panel Discussion
Moderator: Helena Smolak, Editor Pharma – Handelsblatt
Prof. Dr. Karl Broich
President – Federal Institute for Drugs and Medical Devices (BfArM)
Ricardo Gaminha Pacheco
Longevity and Biotechnology Strategic Partnering, BD&L Director – Insilicio Medicine, Cambridge, USA
Mehr Informationen
Christiane Rothkegel, Ph.D.
Regulatory Senior Program Director – Roche – Basel
Mehr Informationen
12:20
Networking Break & Lunch
Smart Clinical Trials – Clinical Development: How AI Makes Trials Faster, Smaller and Smarter
02:00
Best Practices: AI Digital Twins with Foundation Models
Jean-Philippe Vert
Co-Founder und CEO – Bioptimus – Paris
Mehr Informationen
AI in Market Access – Pricing & Reimbursement: From Dossier to Deal – AI in Benefit Assessment
02:20
Automated Market Access: How AI Radically Accelerates the Path from Evidence to Reimbursement
Jonas Ils
Co-Founder – RYVER.AI
02:40
From File to Formula: How AI Is Redefining Pricing and Market Access in Drug Launches
Daniel Moreira
Co Founder – Cellbyte
03:00
Networking Break
Beyond Approval – Care Delivery, Framework Conditions & Post-Market
03:50
Research, Talent, Investment and Business Models – What Framework Does Technology Need in Germany and Europe?
Panel Discussion
Moderator: Helena Smolak, Editor Pharma – Handelsblatt
Dr. Steffen Meyer
State Secretary at the Federal Ministry of Finance (Germany)
Dr. Daniel Steiners
CEO – Roche Pharma AG
Mehr Informationen
Dr. Justus Wolff
Member of the EU Focus Group on AI – Member ISPOR
04:10
Enhancing Efficiency & Quality in Medical Evidence Generation: AI in Post-Approval Studies and Communication
Dr. Monika Gratzke
European Head of Medical Innovation & Digital Strategy – Daiichi Sankyo Europe
Mehr Informationen
04:30
Transforming Clinical Research: Advancing into the Future with AI and Real-World Data
Dr. Benjamin Gmeiner
Director Medical Data Strategy & Science – Novartis Deutschland
04:50
AI Is the Insurance for Your IHC Biomarker Trial
Felix Faber
Founder & Chief Executive Officer – Mindpeak
05:10
Summary of the Day
05:30
End of “Focus Day Technology – AI in Pharma”
from 06:30
International Strategic Meet-Up (sold out)
Science, Strategy & Scale – Shaping Europe’s Pharma Transformation
(Event held in English; off-site location)
06:45
Welcome
07:00
Science, Strategy & Scale – Shaping Europe’s Pharma and Healthcare Transformation under Global Pressure
Panel Discussion
Moderator: Martin Knobbe, Member of the Editorial Board, Handelsblatt
Chantal Friebertshäuser
Senior Vice President Europe, Middle-East and international tenders – Moderna
Prof. Dr. Prof. Dr. Heyo Kroemer
Chair of the Executive Board – Charité – Universitätsmedizin Berlin
Dr. Marc Alexander Mahl
President Pharma, Nutrition & Sustainability – Fresenius Kabi
Mehr Informationen
Marc P. Philipp
Partner & Managing Director – Kearney
Mehr Informationen
Host International Strategic Meet Up
